SPDR S&P Health

Hound Partners LLC Reduced Its Holdings in HCA Healthcare

Guardant Health director sells 1,250 shares at $105 per share

Guardant Health Inc. collaborates with Trial Library to enhance cancer clinical trial accessibility

Guardant Health's CTO Darya Chudova Sells 22,935 Shares

Guardant Health Inc executive Kalia Kumud sold 2,000 shares

Guardant Health Director Disposes of Company Common Stock

State Street Corp reduces holdings in HCA Healthcare

Guardant Health Launches Liquid Biopsy Service in Italy Based on Guardant360® CDx

Hood River Capital Management LLC Increases Holdings in Guardant Health

Guardant Health Inc CFO sells stocks

Guardant Health Director Clark Ian T Sold 28,611 Shares

Guardant Health Inc.'s CBO Chris Freeman Reports Sale of Company Common Stock

Clark Ian T, Director of Guardant Health Inc., Plans to Sell Stocks

HCA Healthcare donates $4.8 million to Pepperdine University's Nursing School

Guardant Health to showcase liquid biopsy data at San Antonio Breast Cancer Symposium

SCS Capital Management LLC Increases Holdings in HCA Healthcare

Norwegian Bank Acquired 460,024 Shares of Universal Health in Q2

Guardant Health insiders sold $5.846 million worth of shares

ARK Invest ETF Significant 增持 Genomics and Autonomous Vehicle Stocks

Guardant Health Exec Monroe Terilyn J Sells $5.8M in Shares

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Hound Partners LLC reduced its stake in HCA Healthcare by 10% in Q2, selling 3,535 shares. HCA now constitutes 1.6% of Hound's portfolio. Institutional investors hold 62.73% of HCA stock. Analysts have a consensus 'Moderate Buy' rating with a target price of $475.95. HCA's Q3 earnings exceeded expectations, with a 9.6% revenue increase year-over-year. The stock opened at $484.67, with a market cap of $110.60 billion.

Market Beat

HCA Healthcare

Hound Partners LLC Sells 3,535 Shares of HCA Healthcare, Inc. $HCA

683 Capital Management LLC reduced its stake in shares of Centene Corporation (NYSE:CNC - Free Report) by 35.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission.

Centene

683 Capital Management LLC Sells 95,000 Shares of Centene Corporation $CNC

Daiwa Securities Group Inc. reduced its stake in Centene Corporation by 18.4% in Q2, selling 28,011 shares. The firm now holds 123,990 shares worth $6.73 million. Other institutional investors also adjusted their positions in Centene. Analysts have mixed ratings on Centene, with a consensus price target of $40.47. Centene reported Q3 earnings of $0.50 per share, beating estimates, with revenue up 18.2% YoY to $49.69 billion.

Centene Corporation $CNC Shares Sold by Daiwa Securities Group Inc.

Guardant Health Director Medina Manuel Hidalgo sold 1,250 shares at $105 each, totaling $131,250. This sale reduced his position by 61.06%. The stock traded down 0.6% to $102.62. Analysts have given the stock a "Moderate Buy" rating with a target price of $80.86. Institutional investors have adjusted their positions in the company.

Guardant Health

Guardant Health (NASDAQ:GH) Director Sells $131,250.00 in Stock

HCA Healthcare Inc.'s stock rose 2.91% to $482.35, outperforming competitors on a strong trading day. The S&P 500 Index increased by 0.21% and the Dow Jones by 1.34%. HCA closed 7.24% below its 52-week high of $520.00. Community Health Systems Inc. fell 1.80%, while Tenet Healthcare Corp. rose 0.12%. Trading volume was below the 50-day average.

Dow Jones

HCA Healthcare Inc. Stock Outperforms Competitors On Strong Trading Day

Robert W. Baird raised Centene's price target from $28.00 to $36.00, maintaining a "neutral" rating. Other analysts have varied ratings, with a consensus price target of $40.47. Centene's stock opened at $39.27, with a market cap of $19.30 billion. The company reported $0.50 EPS for the quarter, surpassing expectations. Hedge funds have adjusted their positions in Centene, which operates healthcare programs in the U.S.

Centene (NYSE:CNC) Price Target Raised to $36.00

Guardant Health Inc. has partnered with Trial Library to enhance access to cancer clinical trials in the U.S. by integrating genomic data with AI-powered patient matching. This collaboration aims to improve enrollment of diverse patient populations in precision oncology trials, offering new treatment opportunities and boosting participation in cancer research.

Reuters

Guardant Health Partners with Trial Library to Expand Access to Cancer Clinical Trials

Health Net, part of Centene Corporation, is providing special assistance to members and providers affected by the Pack Fire in California. Following Gov. Newsom's emergency declaration, Health Net offers emergency medication refills, telehealth services, crisis support, and access to social services. Healthcare providers receive extended grace periods and waived prior authorizations. Health Net continues to update its support measures as the situation evolves.

StockTitan

Health Net Providing Special Assistance to Members and Providers Affected by The Pack Fire in California | CNC Stock News

Guardant Health Insider Sold Shares Worth $10,505,474, According to a Recent SEC Filing

marketscreener

Guardant Health Insider Sold Shares Worth $10,505,474, According to a Recent SEC Filing

03:41 AM EST, 12/11/2025 (MT Newswires) -- Darya Chudova, Chief Technology Officer, on December 08, 2025, sold 22,935 shares in Guardant Health ( GH ) for $2,417,980. Following the Form 4 filing with the SEC, Chudova has control over a total of 66,943 common shares of the company, with 12,463 shares held directly and 54,480 controlled indirectly.SEC Filing: MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

fidelity

Guardant Health Insider Sold Shares Worth $2,417,980, According to a Recent SEC Filing

Talasaz AmirAli Chief Executive Officer of Guardant Health Inc [GH] filed a Form 4 on December 10, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/8/25TransactionSaleShares100,000Price$105.05Value$10,505,480Ending Holdings: 855,746 - IndirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

CEO Talasaz Sells 100,000 ($10.5M) Of Guardant Health Inc [GH]

Kalia Kumud Officer of Guardant Health Inc [GH] filed a Form 4 on December 10, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/8/25TransactionSaleShares2,000Price$104.60Value$209,204Ending Holdings: 22,365 - DirectFor a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Officer Kalia Sells 2,000 ($209.2K) Of Guardant Health Inc [GH]

Chudova Darya Officer of Guardant Health Inc [GH] filed a Form 4 on December 10, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date12/8/25TransactionSaleShares22,935Price$105.43Value$2,417,980Ending Holdings: 66,943 (12,463 - Direct, 54,480 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Officer Chudova Sells 22,935 ($2.4M) Of Guardant Health Inc [GH]

Manuel Hidalgo Medina, a director at Guardant Health Inc., has reported the disposal of common shares of the company. This information was published by Guardant Health Inc. via the EDGAR system of the U.S. Securities and Exchange Commission on December 10, 2025. The news is generated by Public Technologies using AI and is for informational purposes only.

Director Manuel Hidalgo Medina Reports Disposal of Guardant Health Inc. Common Shares

Centene Corp. (CNC) shares rose 1.55% to $38.67 on a strong trading day, outperforming some competitors. The S&P 500 and Dow Jones also saw gains. Despite the rise, Centene is still 42.12% below its 52-week high. Trading volume was below the 50-day average.